Is Abbott Laboratories or Ortoma AB Series B more undervalued?

As of Sep 5, 2026, Abbott Laboratories is at -31% to fair value and Ortoma AB Series B at -82%. Abbott Laboratories is the less overvalued of the two. Model-based estimate, not financial advice.

Which has higher quality, Abbott Laboratories or Ortoma AB Series B?

Abbott Laboratories has a quality score of 67/100 and Ortoma AB Series B 46/100. Abbott Laboratories leads on quality.

STOCK COMPARISON

Abbott Laboratories vs Ortoma AB Series B: Fair Value & Quality

Both stocks run through our valuation models. Here is how Abbott Laboratories (ABT) and Ortoma AB Series B (ORT-B) compare, as of Sep 5, 2026.

As of Sep 5, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Abbott Laboratories trades at $108 versus a fair value of $74.79 (-31%), while Ortoma AB Series B trades at SEK 7.32 versus SEK 1.31 (-82%).

Abbott Laboratories

ABT · USD · Health Care

-31%

upside to fair value

overvalued

Price$108

Fair Value$74.79

Quality67/100

Ortoma AB Series B

ORT-B.ST · SEK · Health Care

-82%

upside to fair value

overvalued

PriceSEK 7.32

Fair ValueSEK 1.31

Quality46/100

Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Abbott LaboratoriesOrtoma AB Series B

Valuation

27.7×P/E (TTM)—

3.89×P/S (TTM)0.98×

3.36×P/B0.29×

15.1×EV/EBITDA—

1.47×PEG—

−31.0%Fair value upside−82.1%

2.3%Dividend yield—

$2.44Dividend per share—

Profitability

13%Operating margin-51%

1.19×EBIT margin trend (5Y)—

12%Return on equity-27%

6%Return on assets-15%

Growth

8%Revenue growth (YoY)-61%

0.5%Avg. growth/yr (3Y)—

5.1%Avg. growth/yr (5Y)—

+10.5%Value creation/yr—

Balance & size

23.6×Interest coverage (EBIT/interest)—

0.19×Debt / equity—

$175BMarket cap$42M

healthyGrowth qualitymixed

Abbott Laboratories leads: 4 to 2 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Abbott Laboratoriesof which business quality 66 · market factors 52 Ortoma AB Series Bof which business quality 49 · market factors 21

ProfitabilityMargins and returns on capital today

Quality GrowthAre margins and returns improving?

CashflowEarnings quality: real cash, not paper profit

Fin. StrengthBalance sheet, leverage, solvency risk

InvestmentDisciplined investing over empire-building

Low VolatilityCalm price path (market factor)

MomentumPrice trend over the last 3–12 months (market factor)

52W MomentumDistance to the 52-week high (market factor)

Net IssuanceBuybacks instead of dilution

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model family	Abbott LaboratoriesPrice $108	Ortoma AB Series BPrice SEK 7.32
DCF Models	-33%below the price$73.01	-76%below the priceSEK 1.76
Earnings-Based	-73%below the price$29.42	n/a
Dividend Discount	-63%below the price$39.73	n/a
Multiples	-35%below the price$70.72	-82%below the priceSEK 1.31
Asset-Based	-81%below the price$20.05	-71%below the priceSEK 2.12
Growth DCF	-38%below the price$67.02	-74%below the priceSEK 1.88
Economic Profit	-65%below the price$37.49	n/a
Growth Earnings	-35%below the price$70.25	n/a
Minimum	-81%below the price$20.05	-82%below the priceSEK 1.31
Maximum	-33%below the price$73.01	-71%below the priceSEK 2.12
Median	-51%below the price$53.37	-75%below the priceSEK 1.82
Geometric mean	-57%below the price$46.36	-76%below the priceSEK 1.74

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Ortoma AB Series B: 7 of 7 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Abbott Laboratories

Bear $51.13Fair Value $74.79Bull $94.43

$108 = current price (white tick)

Ortoma AB Series B

Bear SEK 1.06Fair Value SEK 1.31Bull SEK 1.57

SEK 7.32 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

First stock

Second stock

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Abbott Laboratories · Health Care

Quality score67 · Top 25%

Fair value upside-31% · above median

Ortoma AB Series B · Health Care

Quality score46 · below median

Fair value upside-82% · bottom 25%

Bottom line

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →

Abbott Laboratories · Ortoma AB Series B

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Abbott Laboratories

Abbott Laboratories vs UnitedHealth Group Eli Lilly and vs UnitedHealth Group Johnson & Johnson vs UnitedHealth Group AbbVie vs UnitedHealth Group

Related to Ortoma AB Series B

Merck & Company vs UnitedHealth Group AstraZeneca vs UnitedHealth Group Thermo Fisher Scientific vs UnitedHealth Group Amgen vs UnitedHealth Group

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.